Interpreting change scores for pain and functional status in low back pain: Towards international consensus regarding minimal important change

Spine

Volumn 33, Issue 1, 2008, Pages 90-94

  Ostelo, Raymond W J G ^a,b   Deyo, Rick A ^c   Stratford, P ^d   Waddell, Gordon ^e   Croft, Peter ^f   Von Korff, Michael ^g   Bouter, Lex M ^a,b   De Vet, Henrica C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c UNIVERSITY OF WASHINGTON   (United States)

^d MCMASTER UNIVERSITY   (Canada)

^e CARDIFF UNIVERSITY   (United Kingdom)

^f KEELE UNIVERSITY   (United Kingdom)

^g CENTER FOR HEALTH STUDIES   (United States)

Author keywords

Low back pain; Minimal important change; Outcome measures

Indexed keywords

ARTICLE; CONSENSUS DEVELOPMENT; DISABILITY; FUNCTIONAL ASSESSMENT; HUMAN; INTERNATIONAL COOPERATION; LOW BACK PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; VISUAL ANALOG SCALE;

DISABILITY EVALUATION; EXPERT TESTIMONY; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; INTERNATIONAL COOPERATION; LOW BACK PAIN; NETHERLANDS; NORTH AMERICA; OUTCOME ASSESSMENT (HEALTH CARE); PAIN MEASUREMENT; QUESTIONNAIRES; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX;

EID: 37649018995     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e31815e3a10     Document Type: Article

References (30)

1. Deyo RA, Battie M, Beurskens AJ, et al. Outcome measures for low back pain research. A proposal for standardized use. Spine 1998;23:2003-13.
2. Bombardier C. Outcome assessments in the evaluation of treatment of spinal disorders: summary and general recommendations. Spine 2000;25:3100-3.
3. Roland M, Fairbank J. The Roland-Morris Disability Questionnaire and the Oswestry Disability Questionnaire. Spine 2000;25:3115-24.
4. von Korff M, Jensen MP, Karoly P. Assessing global pain severity by selfreport in clinical and health services research. Spine 2000;25:3140-51.
5. Wright JG. The minimal important difference: who's to say what is important? J Clin Epidemiol 1996;49:1221-2.
6. Juniper EF, Guyatt GH, Willan A, et al. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol 1994;47:81-7.
7. Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol 2003;56:395-407.
8. Roland M, Morris R. A study of the natural history of back pain. I. Development of a reliable and sensitive measure of disability in low-back pain. Spine 1983;8:141-4.
9. Fairbank JC, Couper J, Davies JB, et al. The Oswestry low back pain disability questionnaire. Physiotherapy 1980;66:271-3.
10. Kopec JA, Esdaile JM, Abrahamowicz M, et al. The Quebec Back Pain Disability Scale. Measurement properties. Spine 1995;20:341-52.
11. Beurskens AJ, de Vet HC, Köke AJ, et al. Measuring the functional status of patients with low back pain. Assessment of the quality of four diseasespecific questionnaires. Spine 1995;20:1017-28.
12. Grotle M, Brox JI, Vollestad NK. Concurrent comparison of responsiveness in pain and functional status measurements used for patients with low back pain. Spine 2004;29:E492-E501.
13. Hagg O, Fritzell P, Nordwall A. The clinical importance of changes in outcome scores after treatment for chronic low back pain. Eur Spine J 2003;12:12-20.
14. van der Roer N, Ostelo RW, Bekkering GE, et al. Minimal clinically important change for pain intensity, functional status, and general health status in patients with nonspecific low back pain. Spine 2006;31:578-82.
15. Farrar JT, Young JP Jr, LaMoreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001;94:149-58.
16. Childs JD, Piva SR, Fritz JM. Responsiveness of the numeric pain rating scale in patients with low back pain. Spine 2005;30:1331-4.
17. Stratford PW, Binkley J, Solomon P, et al. Defining the minimum level of detectable change for the Roland-Morris Questionnaire. Phys Ther 1996;76:359-65.
18. Stratford PW, Binkley JM. Measurement properties of the RM-18. A modified version of the Roland-Morris Disability Scale. Spine 1997;22:2416-21.
19. Riddle DL, Stratford PW, Binkley JM. Sensitivity to change of the Roland-Morris Back Pain Questionnaire: part 2. Phys Ther 1998;78:1197-207.
20. Stratford PW, Binkley JM, Riddle DL, et al. Sensitivity to change of the Roland-Morris Back Pain Questionnaire: part 1. Phys Ther 1998;78:1186-96.
21. Davidson M, Keating JL. A comparison of five low back disability questionnaires: reliability and responsiveness. Phys Ther 2002;82:8-24.
22. Wiesinger GF, Nuhr M, Quittan M, et al. Cross-cultural adaptation of the Roland-Morris Questionnaire for German-speaking patients with low back pain. Spine 1999;24:1099-103.
23. Johansson E, Lindberg P. Subacute and chronic low back pain. Reliability and validity of a Swedish version of the Roland and Morris Disability Questionnaire. Scand J Rehabil Med 1998;30:139-43.
24. Nusbaum L, Natour J, Ferraz MB, et al. Translation, adaptation and validation of the Roland-Morris Questionnaire-Brazil Roland-Morris. Braz J Med Biol Res 2001;34:203-10.
25. Stratford PW, Binkley JM. A comparison study of the back pain functional scale and Roland Morris Questionnaire. North American Orthopaedic Rehabilitation Research Network. J Rheumatol 2000;27:1928-36.
26. Stratford PW, Binkley JM, Riddle DL. Development and initial validation of the back pain functional scale. Spine 2000;25:2095-102.
27. Garratt AM, Klaber Moffett J, Farrin AJ. Responsiveness of generic and specific measures of health outcome in low back pain. Spine 2001;26:71-7.
28. Jordan K, Dunn KM, Lewis M, et al. A minimal clinically important difference was derived for the Roland-Morris Disability Questionnaire for low back pain. J Clin Epidemiol 2006;59:45-52.
29. Guyatt GH, Juniper EF, Walter SD, et al. Interpreting treatment effects in randomised trials. BMJ 1998;316:690-3.
30. FDA Guidance on PRO. Guidance for Industry Patient-Reported Outcome Measures. Use in Medical Product Development to Support Labeling Claims. Rockville, MD: Food and Drug Administration; 2006.